Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/17/1999EP0955995A1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
11/17/1999EP0955993A1 Topical composition and method for enhancing lipid barrier synthesis
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999EP0880352B1 Stabilization of naloxone hydrochloride
11/17/1999EP0819135B1 Sugar-modified cytostatics
11/17/1999EP0804576A4 A novel haemopoietin receptor
11/17/1999EP0784604B1 Process for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butan-1-ol
11/17/1999EP0741726B1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/17/1999EP0738273B1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
11/17/1999EP0707477B1 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
11/17/1999EP0688218B1 Interleukin-1 inhibitor
11/17/1999EP0604566B1 Chimeric and/or growth-restricted flaviviruses
11/17/1999EP0572537B1 Cytokine inhibitors
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235608A Alkylated reapamycin derivatives
11/17/1999CN1235606A 2-methoxyphenylpiperazine derivatives
11/17/1999CN1235604A Benzoxazole derivative with affinity to binding sites of amino acid receptors
11/17/1999CN1235603A N-substituted azaheterocyclic compounds
11/17/1999CN1235602A 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic urea useful as HIV protease inhibitors
11/17/1999CN1235601A (4R,5S,6S,7R)-hexahydro-1-[5-(3-aminoinazole) methyl]-3-butyl-5,6-dihydroxy-4,]-bis [phaenylmethyl]-2H-1,3-diazepin-2-one, its preparation and use as HIV protease inhibitors
11/17/1999CN1235599A Biphenyl dicarboxylic acid derivatives and preparation thereof
11/17/1999CN1235597A Heterocycle derivatives inhibiting factor Xa
11/17/1999CN1235596A Cyclic amine derivatives
11/17/1999CN1235594A Methods and compositions for lipidization of hydrophilic molecules
11/17/1999CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections
11/17/1999CN1235554A Antifungal combination therapy
11/17/1999CN1235552A Beta-glucan products and extration from cereals thereof
11/17/1999CN1235550A Synergistic gold-containing compositions
11/17/1999CN1235549A Progesterone for treating or reducing ischemia
11/17/1999CN1235548A Method for lowering plasma levels of lipoprotein (A)
11/17/1999CN1235547A Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
11/17/1999CN1235546A Preventives/remedies for muscle tissue degenerations
11/17/1999CN1235545A Composition, for treatment of asthma, containing loratadine and decongestant
11/17/1999CN1235544A Controlled release dosage form of R-(Z)-alpha-methoxyimino-alpha-(1-azabicyclo 2,2 oct-c-yl) acetonitrile monohydrochloride
11/17/1999CN1235543A Glutathione reductase activity potentiator containing troglitazone
11/17/1999CN1235542A Falty acid treatment
11/17/1999CN1235541A Treatment of spasticity, convulsions by isovaleric acid derivatives CNS
11/17/1999CN1235540A Use of adamantane amines or structurally similar compounds for combating borna disease virus and for prevention and treatment of affective diseases and other disorders associated with BDV infections i
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235513A Nucleic acid and amino acid sequences ralating to helicobacter pylori and vaccine compositions thereof
11/17/1999CN1235512A Method for treating endothelial injury
11/17/1999CN1235156A New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them
11/17/1999CN1235124A Anti-cancer therapy agent of arsenic hexoxide (AS4O6) of natural chemical substance and its pharmaceutical composition
11/17/1999CN1235052A Capsule for regeneration of heart valves
11/17/1999CN1235046A External-use medicine for pharyngitis
11/17/1999CN1235045A Medicinal composite for acne and preparing method thereof
11/17/1999CN1235033A Medicine for osteodynia due to pathogenic wind-dampness
11/17/1999CN1235030A Composite oral liquid of Gaolining and preparing method thereof
11/17/1999CN1235024A Composition for preventing and treating bacterial diseases of young chicken
11/17/1999CN1235023A Mixed povidone iodine disinfectant and preparing method thereof
11/17/1999CN1235022A Composition for treating and preventing coccidiosis of chicken
11/17/1999CN1235021A Composition for treating and preventing sudden death of chicken
11/17/1999CN1235020A Medicinal products of superfined alpha-linolenic acid, preparing process and preparation thereof
11/17/1999CN1235018A Preparation of freeze-dried pantoprazole injection and preparing method thereof
11/17/1999CN1234976A Method for extracting sulphur containing part from garlic and preparation of oil containing sulphur part
11/17/1999CN1046535C Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity and their medicinal compositions
11/17/1999CN1046525C Compounds containing fused bicyclic ring and preparation thereof
11/17/1999CN1046524C Cephalosporin derivatives
11/17/1999CN1046523C Preparation of antimicrobial quinolonyl lactams
11/17/1999CN1046522C Improved process for preparation of D-(+)-biotine intermediate product
11/17/1999CN1046521C Preparation of 4-deoxcide-4-epi-podophyllotoxin derivatives
11/17/1999CN1046520C Bicyclic oxazine and thiazine oxazolidinone
11/17/1999CN1046519C Oxazolyl- and thiazolylimidazo- and thienodiazepines and use as medicaments
11/17/1999CN1046518C Heterocyclic subtituted imidazoloquinoxalinones, preparation and use thereof
11/17/1999CN1046517C Triazolopyridazines, preparation and use thereof
11/17/1999CN1046516C Method for stabilizing compound DX-52-1 and lyophilized composiiton thereof
11/17/1999CN1046515C Diazabicyclic neurokinin antagonists
11/17/1999CN1046514C Melatonin agonist 'beta-carboline derivatives and analogs with naphthalenic structure, preparation thereof and their use as drugs
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/17/1999CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/17/1999CN1046510C Preparation of N-tert-butylamides
11/17/1999CN1046507C Heterocyclic compounds for treatment of CNS and cardiovasular disorders
11/17/1999CN1046506C Preparation of n-tert-butylamides derivatives and their salts
11/17/1999CN1046505C Preparation of 1-benzyl-3-hydroxymethyl-indazole and ether of aliphatic-2-hydroxy acid
11/17/1999CN1046502C 22-thiavitamin D3 derivative
11/17/1999CN1046412C Bone marrow purifying preparation and preparing method thereof
11/17/1999CN1046411C Injection for curing psoriasic
11/16/1999USRE36397 Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity
11/16/1999US5986170 Murine model for human carcinoma
11/16/1999US5986132 Synthesis of carboxylic acid derivatives
11/16/1999US5986131 RXR selective ligands
11/16/1999US5986129 Multistage process of diazotization, acidification, hydrolysis and acylation
11/16/1999US5986114 Benzopyranol derivatives
11/16/1999US5986111 Pyronin antibacterials, process and novel intermediates thereto
11/16/1999US5986109 Benzothiophene compounds, intermediates, compositions, and methods
11/16/1999US5986105 Quinolone- and naphthyridonecarboxylic acid derivatives
11/16/1999US5986103 2-alkyl-1H-imidazole-5-carboxylic acids
11/16/1999US5986100 Pharmaceutical compositions and methods for use
11/16/1999US5986097 Spiro[cyclopent[b]indole-piperidines]
11/16/1999US5986090 Metallized porphyrins
11/16/1999US5986089 Process for the preparation of moenomycin A
11/16/1999US5986083 Identifying single stranded rna target sequence and synthesizing complementary oligomer of mixed nucleosides with alternating racemic aryl- or lower alkyl-phosphonate linkages; has nuclease stability and enhanced hybridization binding
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986055 CDK2 interactions
11/16/1999US5986054 Genetic sequences and proteins related to alzheimer's disease
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986044 Polyureas, polycarbonates, polyesters and polyamide copolymers
11/16/1999US5985938 Method for reducing oxalate
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985936 Using phytosterol compounds to prevent alzheimer's disease